A detailed history of Savvy Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Savvy Advisors, Inc. holds 40,853 shares of AMGN stock, worth $11.8 Million. This represents 2.67% of its overall portfolio holdings.

Number of Shares
40,853
Previous 41,302 1.09%
Holding current value
$11.8 Million
Previous $12.9 Billion 2.0%
% of portfolio
2.67%
Previous 4.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $138,911 - $151,483
-449 Reduced 1.09%
40,853 $13.2 Billion
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $499,750 - $607,327
1,902 Added 4.83%
41,302 $12.9 Billion
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $27,693 - $33,429
103 Added 0.26%
39,400 $11.2 Billion
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $10 Million - $11.3 Million
39,297 New
39,297 $11.3 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Savvy Advisors, Inc. Portfolio

Follow Savvy Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savvy Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Savvy Advisors, Inc. with notifications on news.